Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed
Philip Kenol

Philip Kenol

Policy & Advocacy Officer

Philip manages the coalition’s multilateral policy analysis and advocacy work. He develops and implements outreach strategies to the various United Nations agencies and other multilateral organizations to ensure that the coalition is advocating a consistent position with all global health R&D stakeholders.

Philip has a background in global development policy and health care. Before joining GHTC, he served two years as a Senior Dedicated Advisor at the Advisory Board Company, working with hospitals and health care providers on issues surrounding burnout, patient safety, and engagement.

Prior to the Advisory Board, he managed the Alliance for Global Health and Competitiveness, a coalition of private companies and nonprofits that promote strategic investments in health care in developing and middle-income countries. As part of that work, he led lobbying efforts, helped forge new partnerships, and managed high-level roundtables to explore the challenges health decision-makers face.

He started his career at the German Marshall Fund, focusing on economic and development policy, and has worked on several political campaigns, including President Obama’s 2008 run.

Philip received his BA in Government (with a concentration in international development) from Dartmouth College. In his free time, you can usually find Philip playing soccer, rooting for the Capitals, and playing district trivia.

Articles written by Philip

A new hope: How the WHO Executive Board meeting signaled the need for a global pivot for global health R&D
United States Mission Geneva
February 5, 2021

A new hope: How the WHO Executive Board meeting signaled the need for a global pivot for global health R&D

The 148th session of the World Health Organization Executive Board came to a close last week, signaling a potential pivot point for global health. As the world continues to battle a devastating pandemic, here's a look at how 2021 could present fresh opportunities to strengthen the global R&D ecosystem.
Philip Kenol GHTC
Read more
Key takeaways from the 73rd World Health Assembly
United States Mission Geneva
November 19, 2020

Key takeaways from the 73rd World Health Assembly

The 73rd World Health Assembly convened virtually November 9-14 to address the ongoing COVID-19 pandemic as well as other key global health priorities. GHTC tracked the proceedings and worked with partners to weigh in on key agenda items. Here are our top takeaways from this year’s assembly.

Philip Kenol GHTC
Read more
Global pandemic preparedness panel urges increased support for R&D
Dean Calma / IAEA
September 17, 2020

Global pandemic preparedness panel urges increased support for R&D

The COVID-19 pandemic has revealed a collective failure to take pandemic prevention, preparedness, and response seriously and prioritize it appropriately, according to a report released by the Global Preparedness Monitoring Board. In their recommendations, the board underscores the importance of strengthening the global health R&D ecosystem to prepare for future threats. Here we breakdown what they said.

Philip Kenol GHTC
Read more
WHO’s vital role in global R&D response to COVID-19
US Mission Geneva
May 22, 2020

WHO’s vital role in global R&D response to COVID-19

The COVID-19 crisis has demonstrated just how crucial multilateral conveners like WHO are to our collective health, prosperity, and security and the need for enhanced international cooperation and worldwide solidarity.

Philip Kenol GHTC
Read More
3 takeaways from the WHO Executive Board meeting
WHO
February 14, 2020

3 takeaways from the WHO Executive Board meeting

With the global health emergency of the novel coronavirus looming large, last week the global health community gathered in Geneva to kick off the World Health Organization (WHO) Executive Board (EB) meeting. GHTC was on the scene following the official agenda and delivering statements. Here are our top three takeaways from this year’s EB.

Philip Kenol GHTC
Read More
Explainer: the Nagoya Protocol and its impact on global health R&D
PATH/Matthew Dakin
November 26, 2019

Explainer: the Nagoya Protocol and its impact on global health R&D

The World Health Organization recently announced that at its upcoming Executive Board meeting in February member states will discuss challenges and issues in implementing the Nagoya Protocol—a legal framework that governs the access to and benefits gained through the sharing of genetic resources including human and animal DNA, plants, and pathogens. As these discussions heat up, GHTC is taking a brief look at what the Nagoya Protocol is, how it impacts global health R&D, and what’s next for the future of this framework.

Philip Kenol GHTC
Read More
What’s next for universal health coverage?
UN Photo/Loey Felipe
September 27, 2019

What’s next for universal health coverage?

United Nations members unanimously adopted a high-level political declaration on universal health coverage (UHC), but while the adoption of the declaration is welcome news, in many ways it represents a starting point for the next phase of UHC, in which the thornier issues of financing, follow through, and accountability will rise to the forefront.

Philip Kenol GHTC
Read More
3 takeaways from the inaugural Global Health Security Conference
PATH/Gabe Bienczycki
June 27, 2019

3 takeaways from the inaugural Global Health Security Conference

Last week, the Australian government and the Indo-Pacific Centre for Health Security convened practitioners, researchers, educators, and decision-makers across the fields of public health, medicine, veterinary science, agriculture, government, defense, and anthropology for the first Global Health Security Conference in Sydney to examine the progress made to date in strengthening health systems and to identify gaps and opportunities for enhancing the international community’s ability to respond more efficiently and effectively to future health crises.

Philip Kenol GHTC
Read More
  • 1
  • 2
  • Next

GHTC Team

Jamie Bay Nishi, MS
Jamie Bay Nishi, MS

Director

Learn More about Jamie
Marissa Chmiola
Marissa Chmiola

Senior Communications Lead

Learn More about Marissa
Emily Conron
Emily Conron

Policy and Advocacy Officer

Learn More about Emily
Philip Kenol
Philip Kenol

Policy & Advocacy Officer

Learn More about Philip
Julien Rashid
Julien Rashid

Policy and Advocacy Associate

Learn More about Julien
Anna Kovacevich
Anna Kovacevich

Program Assistant

Learn More about Anna

Steering Committee

Rachel M. Cohen, MA
Rachel M. Cohen, MA

Regional Executive Director, North America

Drugs for Neglected Diseases initiative

Learn More about Rachel
Jodie Curtis
Jodie Curtis

Washington Representative

American Society of Tropical Medicine and Hygiene

Learn More about Jodie
Kevin Fisher
Kevin Fisher

Director of Policy, Data & Analytics

AVAC

Learn More about Kevin
Karen A. Goraleski, MA
Karen A. Goraleski, MA

CEO

American Society of Tropical Medicine and Hygiene

Learn More about Karen
Heather Ignatius, MA
Heather Ignatius, MA

Director, US and Global Advocacy

PATH

Learn More about Heather
Sharyn Tenn, MA
Sharyn Tenn, MA

Senior Advisor, Global Access

International Partnership for Microbicides

Learn More about Sharyn
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

Site managed by A3CS

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In